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Abstract 
Inflammatory pain comprises bidirectional communication between the immune and nervous 
system that results in a myriad of changes within the somatosensory system. This results in amplified 
transmission of nociceptive signals and the unmasking of neural circuits that enable innocuous 
stimuli to drive central pain circuitry following injury. With increasing use of techniques to 
genetically ablate or manipulate molecularly defined neuronal subtypes our understanding of 
nociceptor plasticity mechanisms and the spinal and supraspinal circuits that are recruited is rapidly 
expanding. Here this inflammatory neural plasticity is reviewed, highlighting recent insights that 
shed light upon nociceptor and central mechanisms that promote hyperalgesia and also the central 
unmasking of allodynia circuitry. 
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Introduction 
Inflammatory pain that occurs following tissue injury or in chronic inflammatory diseases such as 
arthritis manifests due to plasticity within both peripheral and central pain pathways, termed 
peripheral and central sensitisation, respectively. Since the early electrophysiological recordings by 
Bessou and Perl in 1969[1] demonstrating the ‘decrease in threshold for activation and enhanced 
response’ of nociceptors that is termed peripheral sensitisation and the flexor motor neuron 
recordings by Clifford Woolf in 1983[2] demonstrating hyper-excitable spinal responses (novel 
spontaneous activity, novel innocuous responses and  enhanced receptive field sizes) that defined 
central sensitisation, our knowledge of the mechanisms and neural circuits driving inflammatory 
pain plasticity has flourished. The resultant inflammatory pain symptoms of allodynia (touch-evoked 
pain), hyperalgesia (exaggerated pain) and spontaneous (non-evoked) pain are recognised as 
important protective neural responses to guard injured tissue during the healing process. However, 
when this neural plasticity persists beyond the healing process then symptoms become maladaptive 
and there is transition to persistent pain.  
This review will summarise peripheral and central plasticity mechanisms underlying inflammatory 
pain, highlighting recent pertinent studies.  There will be a particular focus on nociceptor plasticity, 
spinal pain circuits and the descending pain modulatory system.   
 
Peripheral plasticity 
Neuro-immune interactions 
Tissue injury and inflammation results in the release of numerous inflammatory mediators such as 
bradykinin, Nerve Growth Factor (NGF), prostaglandin E2 (PGE2) and pro-inflammatory cytokines 
and chemokines from, for example, damaged tissue cells and immune cells[3,4] . These 
inflammatory mediators act on their respective receptors present on peripheral nociceptor terminals 
to ‘activate’ or ‘sensitise’ the nociceptor terminal. Sensitisation occurs via activation of intracellular 
signalling pathways (MAP kinase/PKA/PKC/adenylyl cyclase) that drive the phosphorylation and 
modulation of transducer receptors and voltage-gated ion channels in the nociceptor terminal. This 
acts to decrease the threshold for action potential firing and via modulation of ion channels such as 
HCN2 increase nociceptor firing rates[4-6]. These modifications occur rapidly to enable the 
somatosensory system to dynamically respond to injury. As a result there is ongoing nociceptive 
afferent drive to the CNS and amplified nociceptive inputs. There is also translational and 
transcriptional regulation of gene expression that modifies nociceptor phenotype and function that 
is relevant for pain persistence[7]. 
It is now increasingly recognised that interactions between the immune and the nervous system in 
inflammatory pain are bidirectional[8,9]. Nociceptor activity following tissue injury can drive 
backpropagating action potentials in nociceptors via local axon reflexes and dorsal root reflexes[10]. 
This concurrent nociceptor antidromic activity induces neurogenic inflammation, via release of 
factors such as calcitonin gene-related peptide and substance P from peripheral nociceptor 
terminals that increases vascular permeability and causes oedema. Recent studies demonstrate that 
these nociceptor derived mediators can also regulate innate and adaptive immune responses that 
further impacts inflammatory pain[8,9]. Interestingly, immune cells not only release pro-
inflammatory mediators they also produce specialised pro-resolution mediators, such as resolvins 
and protectins, derived from omega-3 unsaturated fatty acids that not only resolve inflammation but 
can activate specific receptors on nociceptors to alter their function[11-14]. 
 Recent nociceptor insights 
Silent nociceptors are a special class of nociceptors, long appreciated to be mechano-insensitive but 
have the capacity to acquire mechanical sensitivity under inflammatory pain conditions.  Recently 
Prato et al. (2017)[15] have discovered the molecular mechanism by which this unsilencing occurs. 
First they identified a molecular marker, the nicotinic acetylcholine receptor subunit alpha-3 
(CHRNA3) that defines this mechano-insensitive subset of peptidergic C-fibre nociceptors that 
innervate viscera and deep somatic tissue. Then they demonstrated that the inflammatory mediator 
NGF confers mechanical sensitivity in these neurons that is mediated by the mechanically-gated ion 
channel Piezo2. What remains to be elucidated is why these silent nociceptors lack mechanical 
sensitivity despite expressing PIEZO2 under control conditions and the mechanism by which NGF 
unmasks this Piezo2 mediated mechanosensation. 
Studies of peripheral pain plasticity have mainly focussed on the processes that alter the sensitivity 
of the nociceptor terminal, within inflamed tissue, but less so on the transmission of action 
potentials from the peripheral nociceptor terminal along afferent fibres to their central terminals in 
the spinal cord dorsal horn. However, recent work highlights plasticity at both the cell body and 
afferent fibre level that can regulate nociceptive drive to the CNS. Using in vivo confocal imaging to 
monitor DRG neuronal calcium responses, Kim et al. (2016)[16] revealed coupled activation of DRG 
neurons, via electrical gap junctions,  during tissue inflammation that by amplifying afferent input to 
the CNS contributes to inflammatory mechanical hyperalgesia.  In addition to DRG neuronal 
electrical transmission Du et al. 2017[17] has provided evidence for GABAergic neurochemical 
transmission that regulates action potential propagation through the DRG and thereby nociceptive 
input to the spinal cord. It will be of interest to learn whether this DRG GABAergic communication is 
modified following injury. Furthermore, we have demonstrated that the temporal relay of pain 
signals in nociceptive C-fibre afferents is altered in inflammatory pain[18], consistent with prior 
studies of the inflammatory mediator NGF[19,20] including in humans[21]. Specifically, peripheral 
inflammation reduces activity-dependent slowing of C-fibre conduction velocity, interestingly in a 
sex-dependent manner. We show that this tightens up synaptic transmission of nociceptive inputs 
and promotes spinal summation that we propose contributes to hyperalgesia. 
To date there is fairly limited understanding of the primary sensory neuron subtypes that drive and 
mediate inflammatory pain symptoms. Beyond the seminal observation, using genetic neuronal 
ablation, that NaV1.8  expressing neurons are required for inflammatory pain[22] confirmed with 
optogenetic silencing[23], subsequent neuronal ablation studies suggest differential involvement of 
the MRGPRD subset in inflammatory mechanical hypersensitivity and GINIP-expressing neurons in 
formalin evoked pain[24-26]. Given the revolution in our understanding of the different subclasses 
of DRG neurons and their molecular signatures through transcriptomic studies[27,28] this will 
undoubtedly be exploited in future studies employing genetic ablation, optogenetic or chemogenetic 
approaches to further our understanding of the nociceptor subtypes key for inflammatory pain. 
Another area of significant future interest is the involvement of epidermal cells in somatosensory 
transduction. Evidence suggests that both Merkel cells and keratinocytes transduce mechanical 
stimuli and communicate with sensory afferents via serotonergic and ATP-P2X4 signalling, 
respectively, to facilitate mechanosensation[29,30] but it is not yet known whether these processes 
are involved or regulated in inflammatory pain[31]. 
 
Central plasticity 
Spinal circuits 
Primary hyperalgesia that develops at the site of an injury is considered to result from the peripheral 
sensitisation mechanisms described above in combination with homosynaptic potentiation of 
nociceptor spinal synapses[32]. Secondary hyperalgesia that develops outwith the injury site and 
widespread allodynia is generally regarded to result from central spinal plasticity[32,33]. Since the 
discovery of central sensitisation, it has been known that activity in C-fibre nociceptors is the 
necessary ‘trigger’ to elicit this enhanced excitability within spinal sensory pathways[2]. C-fibres 
induce plasticity via elevated glutamatergic and neuropeptide neurotransmission with spinal 
neurons that raises intracellular calcium and induces kinase activation (PKA/PKC/CamKII/ERK) that 
drives rapid post-translational and also longer term translational and transcriptional changes[7].  
This plasticity manifests as increased local excitatory control[32,34], decreased local inhibitory 
control[35,36] as well as altered descending control[37-39]. Importantly, there are also bidirectional 
neuronal-glial interactions that are integral to this central plasticity[40,41]. As a result of this C-fibre 
driven spinal hyperexcitability,  it is believed that thinly myelinated A-fibre primary afferents and 
touch-sensitive myelinated A-fibres are now able to gain access to specific spinal circuitry, via 
heterosynaptic facilitatory mechanisms, enabling these afferents to ‘mediate’ the sensations of 
mechanical hyperalgesia and mechanical allodynia, respectively[32,33]. I have observed unmasking 
of monosynaptic A inputs to lamina I nociceptive output neurons under inflammatory pain 
conditions that potentially may be relevant for mechanical hyperalgesia[42]. Furthermore, we 
identified a putative ‘allodynia’ circuit – a polysynaptic circuit between Aβ fibres and lamina I 
nociceptive output neurons that is normally under local inhibitory control[43]. 
Identification of this spinal allodynia circuit that provides a route for communication between touch-
sensitive afferents and ascending pain pathways, has been an area of significant research 
focus[31,44-56]. Recent optogenetic, chemogenetic and genetic neuronal ablation studies have 
begun to identify the excitatory interneurons within this polysynaptic circuit and provide insight into 
their connectivity and also the inhibitory interneurons that regulate this circuit.  VGlut3, transiently 
expressing lamina III neurons, somatostatin lamina II/III neurons, calretinin lamina II neurons and 
potentially cholecystokinin deep dorsal horn neurons[57] are excitatory interneurons within 
allodynia circuits recruited under inflammatory pain conditions[50-52]. These excitatory allodynia 
circuits are gated by superficial dynorphin inhibitory neurons[50] and also early RET+ deep dorsal 
horn inhibitory neurons[53]. Interestingly, overlapping yet distinct allodynia circuits are thought to 
be recruited in inflammatory versus neuropathic pain conditions[51,54]. Following nerve injury, 
excitatory lamina IIi PKC neurons, that are gated by lamina II/III parvalbumin inhibitory neurons[55] 
are recruited rather than the calretinin neurons engaged in inflammatory pain[51].  Moreover, there 
is evidence for distinct circuitries for dynamic versus punctate mechanical allodynia in both 
inflammatory and neuropathic pain[56]. In the future similar studies will likely capitalise on the 
recent transformation in our understanding of molecularly defined dorsal horn neuronal 
subtypes[58,59] to further our understanding of the allodynia circuits recruited following injury. 
Recent findings have shed light on the myelinated Aβ-fibre mechanoreceptors that activate these 
spinal allodynia circuits following injury. There is compelling evidence that low threshold 
mechanoreceptors expressing the stretch-gated ion channel Piezo2 are required to activate spinal 
allodynia circuits in both inflammatory and neuropathic conditions[60,61] and these may include 
mechanoreceptors expressing the delta opioid receptor[62]. TrkB expressing A-fibre 
mechanoreceptors are required for neuropathic allodynia but they do not appear to be required for 
inflammatory allodynia[63,64]. Development of therapeutic strategies to selectively block activity in 
A-fibres driving allodynia circuits has only been explored thus far for neuropathic pain[63,65,66]. 
 
Supraspinal circuits 
Spinal output neurons project to a number of sites including the thalamus, parabrachial area and the 
periaqueductal grey region (PAG)[67]. From the thalamus there are projections to the 
somatosensory cortex and insular cortex likely relevant for discriminative and affective aspects of 
sensory processing, respectively. Projections from the parabrachial area target the amygdala and 
hypothalamic components of the limbic system and are also likely important for the affective pain 
component. Recently it was discovered that the parabrachial area directly relays nociceptive 
information to the rostral ventromedial medulla (RVM)[68,69]. The RVM is long known to receive 
strong input from the PAG and drive descending serotonergic pathways to bi-directionally modulate 
spinal pain circuits whereas descending noradrenergic pathways from the locus coeruleus exert 
inhibitory spinal control[39]. Plasticity occurs within these various supraspinal regions and their 
connections in inflammatory pain conditions[38,70-72]. Dysregulation in the descending pain 
modulatory system has received much attention[37-39] with descending serotonergic systems 
promoting inflammatory mechanical hypersensitivity [73,74] and descending noradrenergic systems 
limiting inflammatory thermal hyperalgesia and formalin-induced pain behaviours[75]. Interestingly, 
it has been shown that descending dopaminergic circuits are particularly important for the transition 
from acute to chronic inflammatory pain[76]. In this final section I will highlight 3 innovative studies 
identifying novel descending control systems relevant for inflammatory pain. 
It has recently been shown that hindpaw inflammation induces gamma oscillations in the primary 
somatosensory(S1) cortex[77]. Interestingly evidence suggests that this oscillatory activity, likely 
through direct connections with the RVM, drives descending serotonergic pathways to specifically 
facilitate mechanical allodynia. Moreover, direct corticospinal connections, originating in primary 
and secondary somatosensory cortex that target deep dorsal horn neurons, including 
cholecystokinin interneurons, have recently been identified and shown to be required for recruiting 
spinal allodynia circuits in neuropathic conditions and likely also inflammatory pain[57]. Furthermore 
descending oxytocin projections from hypothalamic paraventricular parvocellular neurons that 
target deep dorsal horn wide dynamic range neurons, alongside collateral projections to the 
supraoptic nucleus that drive peripheral oxytocin release have been identified that are proposed to 
limit inflammatory hyperalgesia[78].  
Conclusion 
Our understanding of the plasticity and neural circuits that underlie inflammatory pain is rapidly 
expanding with increased interrogation of neuro-immune interactions and genetic manipulation of 
neuronal subtypes within pain circuitry (summarised Figure 1).  These approaches can be further 
exploited to carefully dissect the neuronal mechanisms essential for induction vs maintenance of 
inflammatory pain and also identify the circuits that mediate specific symptoms. The timing of 
activity within these pain transmitting and gating circuits will also be of significance [79,80].   It will 
be of interest to further appreciate how different mechanisms and circuits are differentially 
activated by various types of injury and how these are influenced by sex, environmental and genetic 
factors[81]. Moreover, it will be key to identify the interactions and circuits most relevant for 
persistence of inflammatory pain following tissue healing. 
 
Figure legend 
Figure 1. Inflammatory pain neural plasticity schematic. Overview of the most recent insights in to 
inflammatory pain mechanisms and circuits illustrated in blue text/connections.  Black 
text/connections denote prior established inflammatory pain mechanisms and circuits. Excitatory 
interneurons within spinal allodynia circuits and the inhibitory interneurons that gate these circuits 
are listed. LC; locus coeruleus, NA; noradrenaline; RVM; rostral ventromedial medulla, 5HT; 
serotonin. 
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Figure legend 
Figure 1. Inflammatory pain neural plasticity schematic. Overview of the most recent insights in to 
inflammatory pain mechanisms and circuits illustrated in blue text/connections.  Black 
text/connections denote prior established inflammatory pain mechanisms and circuits. Excitatory 
interneurons within spinal allodynia circuits and the inhibitory interneurons that gate these 
circuits are listed. LC; locus coeruleus, NA; noradrenaline; RVM; rostral ventromedial medulla, 5HT; 
serotonin. 
 
 
